S-1 plus nab -paclitaxel is a promising regimen for pancreatic cancer in a preclinical model-Reference-Cited by-同舟云学术

S-1 plus nab -paclitaxel is a promising regimen for pancreatic cancer in a preclinical model

Published:2016-01-12 Issue:4 Volume:113 Page:413-419
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Suenaga Masaya¹,Yamada Suguru¹,Fujii Tsutomu¹,Tanaka Chie¹,Kanda Mitsuro¹,Nakayama Goro¹,Sugimoto Hiroyuki¹,Koike Masahiko¹,Fujiwara Michitaka¹,Kodera Yasuhiro¹

Affiliation:

1. Department of Gastroenterological Surgery (Surgery II); Nagoya University Graduate School of Medicine; Nagoya Japan

Funder

Yasuhiro Kodera has received grants and endowments from Taiho Pharmaceutical Co.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24147/fullpdf

Reference49 articles.

1. Epidemiology of pancreatic cancer: An overview;Raimondi;Nat Rev Gastroenterol Hepatol,2009

2. Pancreatic cancer;Vincent;Lancet,2011

3. Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: Positive peritoneal cytology may not confer an adverse prognosis;Yamada;Ann Surg,2007

4. Extended lymphadenectomy in pancreatic cancer is crucial;Fujii T;World J Surg,2013

5. Epithelial-to-mesenchymal transition predicts prognosis of pancreatic cancer;Yamada;Surgery,2013

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nab-paclitaxel plus S-1 versus nab-paclitaxel plus gemcitabine in patients with advanced pancreatic cancer: a multicenter, randomized, phase II study;The Oncologist;2024-07-11

2. Efficacy of nab‑paclitaxel vs. Gemcitabine in combination with S‑1 for advanced pancreatic cancer: A multicenter phase II randomized trial;Oncology Letters;2024-02-19

3. Tumor fibrosis correlates with the survival of patients with pancreatic adenocarcinoma and is predictable using clinicoradiological features;European Radiology;2022-04-14

4. Nab-paclitaxel plus tegafur gimeracil oteracil potassium capsule (S-1) as first-line treatment for advanced biliary tract adenocarcinoma: a phase 2 clinical trial;Hepatobiliary Surgery and Nutrition;2021-01

Efficacy and Safety of Nab-Paclitaxel Plus S-1 versus Nab-Paclitaxel Plus Gemcitabine for First-Line Chemotherapy in Advanced Pancreatic Ductal Adenocarcinoma

;Cancer Management and Research;2020-12